This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Epidemiology

Authoring team

Some information about the epidemiology of renal stones is presented below (1,2,3):

  • overall prevalence of urinary calculi is:
    • assuming a life expectancy of 81 years, the lifeime prevalence equals approximately 13.0% (2,3) - patients treated solely in the community are not included in this estimate (2,3)
    • urolithiasis is a common disease and has been becoming more prevalent in the Western world in recent years - however, this trend seems to be slowing down in England since 2010 (3)
    • Wilcox et al state that the "incidence of kidney stone disease (urolithiasis) has a lifetime risk of 10–15%, and a recurrence rate of 50% within 10 years" (4)

  • males are affected more than females - 2.5:1

  • bimodal age distribution - peak incidences in mid-20's and mid-50's, the later peak principally due to infective stones in women

  • upper tract calculi predominate in developed countries

  • bladder calculi are more common in developing countries

  • stones are unilateral in approximately 80% of cases

  • across the population right and left upper tracts are equally affected

  • incidence of upper tract calculi is increasing (2,3)
    • number of upper urinary tract (UUT) stone hospital episodes increased by 63% to 83,050 in the 10-year period 2000/2001 to 2009/2010
    • total number of UUT stone hospital episodes increased slightly from 83 050 in 2009-2010 to 86 742 in 2014-2015 (4.4% increase).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.